Evolus, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Indemnification Agreements (1 contract)
- Sales Agreements (1)
- Services Agreements (1)
- Settlement Agreements (3)
- Supply Agreements (4)
- Fifth Amendment to Supply Agreement, dated as of April 20, 2023, by and between Daewoong Pharmaceutical Co. Ltd. and Evolus, Inc (Filed With SEC on August 2, 2023)
- Fourth Amendment to Supply Agreement, dated December 12, 2022, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on December 13, 2022)
- Settlement and License Agreement, dated February 18, 2021, by and among Evolus, Inc., Allergan Limited, Allergan, Inc., Allergan Pharmaceuticals Ireland and Medytox, Inc (Filed With SEC on May 12, 2021)
- Settlement and License Agreement, dated February 18, 2021, by and between Evolus, Inc. and Medytox, Inc (Filed With SEC on May 12, 2021)
- Confidential Settlement and Release Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)
- Third Amendment to Supply Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)
- Sales Agreement, dated March 26, 2021, by and between Evolus, Inc. and SVB Leerink LLC as Sales Agent (Filed With SEC on March 26, 2021)
- Form of Indemnification Agreement by and between the Registrant and its directors and officers (Filed With SEC on January 25, 2018)
- Services Agreement, dated as of January 23, 2018, by and between ALPHAEON Corporation and the Registrant (Filed With SEC on January 25, 2018)
- Exclusive Distribution and Supply Agreement, dated as of November 30, 2017, by and between Clarion Medical Technologies Inc. and the Registrant (Filed With SEC on January 9, 2018)
